Proton Pump Inhibitor (PPI)
Micronutrient Consequences of Long Term Proton Pump Inhibitor Therapy
... PPIs have been a remarkable success story. Omeprazole was the first proton-pump inhibitor to be introduced in Europe in 1988. It was quickly shown to be superior to all previously available ...
7
Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions
... to proton pump inhibitor (PPI) ...of PPI-refractory GERD are numerous and diverse, and include adherence, persistent acid, functional disorders, nonacid reflux, and PPI ...
16
Evaluation of costs accrued through inadvertent continuation of hospital-initiated proton pump inhibitor therapy for stress ulcer prophylaxis beyond hospital discharge: a retrospective chart review
... patients. Proton pump inhibitor (PPI)-based stress ulcer prophylaxis (SUP) has been widely prescribed in noncritically ill patients who are at low risk for clinically significant bleeding, ...
9
Chronic use of proton pump inhibitor: A Narrative Review
... a proton pump inhibitor was associated with a significantly increased risk of NIA (Blank et ...a PPI and its monitoring is especially indicated when the patient has risk factors for ...
6
Esophageal Strictures during Treatment with a Proton Pump Inhibitor
... Background: The development of esophageal stricture during treatment with high dose chemo- therapeutic agents is well known and documented in the literature. With the introduction of pro- ton pumps inhibitors ...
7
CYP2C19 Phenotype and Risk of Proton Pump Inhibitor–Associated Infections
... of PPI start, sex, PPI dose (average mg/kg per day), and comorbidities (including a dichotomous variable for the presence or absence of comorbidities as well as dichotomous variables for the presence or ...
10
A Review on Proton Pump Inhibitor for The Treatment of Peptic Ulcer
... PPIs and other antisecretory agents cause Hypergastrinemia by inhibiting gastric acid secretion. The rise in serum gastrin levels is usually modest. The elevated gastrin values return to normal Within 4 weeks after ...
11
Clopidogrel and proton pump inhibitor (PPI) interaction: separate intake and a non-omeprazole PPI the solution?
... Considering the high prevalence of patients taking clopidogrel and aspirin and the need for gastroprotec- tion, prospective randomized trials with clinical end- points that examine the safest and most effective drug ...
5
Perceptions of patient-centered care among veterans with gastroesophageal reflux disease on proton pump inhibitor therapy
... on PPI therapy perceive care, and (2) harnessing patient perspectives that can be used to optimize care experiences to better align with the unique needs and preferences within this ...
13
STABILITY ENHANCEMENT OF PROTON PUMP INHIBITOR IN STOMACH: FORMULATION AND IN VITRO EVALUATION OF STABILIZED PROTON PUMP INHIBITOR
... Proton pump inhibitors are majorly used in the treatment of peptic ulcer disease, gastroesophageal reflux disease in adults and children, risk reduction of non-steroidal anti-inflammatory drugs-associated ...
5
The association between celiac disease and eosinophilic esophagitis in children and adults
... The diagnosis of both EoE and CD was made in three patients, all of whom were males in the pediatric age group. No adults were diagnosed with both conditions. The pertinent clinical, endoscopic and histological de- tails ...
6
High risk of gastrointestinal hemorrhage in patients with systemic sclerosis
... Abbreviations GI: Gastrointestinal; SSc: Systemic sclerosis; COPD: Chronic obstructive pulmonary disease; PPI: Proton pump inhibitor; H2RA: Histamine type 2 receptor antagonist; NSAID: N[r] ...
8
Risk score to predict gastrointestinal bleeding after acute ischemic stroke
... PPI: Proton pump inhibitor; AIS-GIB score: Acute Ischemic Stroke associated Gastrointestinal Bleeding Score; CNSR: China National Stroke Registry; CICAS: the Chinese Intracranial ...
9
EFFECT OF ANTIREFLUX THERAPY ON THE VOICE OUTCOMES OF PHONOMICROSURGERY FOR VOCAL FOLD POLYPS
... of PPI and sodium alginate, on the voice outcome after phonomicrosurgery of vocal fold ...of proton pump inhibitors (omeprazole 20mg twice daily plus liquid alginate (gaviscon advance) one table ...
9
Gastric Mucosal Atrophy Might Be Associated with the Efficacy of First Line Therapy Using Vonoprazan for Helicobacter pylori
... DOI: 10.4236/ojgas.2017.79026 249 Open Journal of Gastroenterology Figure 2. Eradication rate of first-line therapy according to patients’ age, years of admin- istration Differences in the rate of first-line eradication ...
17
Electroacupuncture to treat gastroesophageal reflux disease: study protocol for a randomized controlled trial
... disease; PPI: proton pump inhibitor; EA: electroacupuncture; ESP: esophageal sphincter pressure; TLESRs: transient lower esophageal sphincter relaxations; RCTs: randomized controlled trials; ...
11
Download Download PDF
... includes PPI, amoxicillin, and clarithromycin in triple therapy and addition of Bismuth salt in quadruple ...of proton-pump inhibitor ...
6
A Retrospective Study on Prescribing Patterns and Cost Analysis of Proton Pump Inhibitors
... prescribing proton pump inhibitor drugs (PPIs), (In 2006 PPI was the third most frequently prescribed drug in ...of proton pump inhibitors (PPIs) in the ...
73
Proton pump inhibitor omeprazole attenuates hyperoxia induced lung injury
... Fifteen does 96 pups were used for the assessment of lung function and histology morphometry and immunohistochemistry at day 5 of life Omeprazole was administered prenatally to the doe 2[r] ...
13
Review Article Association between proton pump inhibitors use and kidney diseases: a meta-analysis
... “proton pump inhibitor” or “proton pumps” or “anti- ulcer agent” or “antacid” or “esomeprazole” or “omeprazole” or “ilaprazole” or “dexlansopra- zole” or “rabeprazole” or “lansoprazole” or ...
9